Evidence / living archive
Evidence
Daily evidence updates
Each update is a concise, source-linked reading of new research within Microbiomer's defined scope. It records the study, the reported finding and the limit on the conclusion. Inclusion means that a study matters to that day's account; it is not an endorsement or a final evidence verdict.
Published territory
Browse the daily archive
Twenty-four positions form one desktop field. Published updates become known territory; unfilled positions remain visibly open.
Daily microbiome literature · 14 October 2026
A clinical intervention during platinum-based chemotherapy and a single-arm pilot in perimenopausal women reported gastrointestinal and hormonal outcomes with important design and reporting limits.
Open update ↗Daily microbiome literature · 13 October 2026
A randomised tea trial, a pregnancy cohort, and a small single-arm medical-food study reported outcomes with different evidential limits.
Open update ↗Daily microbiome literature · 11 October 2026
No eligible human intervention studies were included from today's PubMed records.
Open update ↗Daily microbiome literature · 10 October 2026
No eligible human intervention studies were included from today's PubMed records.
Open update ↗Daily microbiome literature · 9 October 2026
No eligible human intervention studies were included from today's PubMed records.
Open update ↗Daily microbiome literature · 8 October 2026
No eligible human intervention studies were included from today's PubMed records.
Open update ↗Zinc–probiotic trial and walnut-metabolite MRI analysis
Two human studies reported biomarker results in adults with IBS and cognitively healthy older adults.
Open update ↗Dietary fatty acids altered bile-acid and cholesterol markers
A secondary crossover analysis in 17 postmenopausal women compared diets enriched in stearic, palmitic or oleic acid.
Open update ↗Probiotics did not improve psoriatic arthritis response
A 12-week randomized placebo-controlled trial found no statistically supported improvement in the primary treatment-response outcome.
Open update ↗Daily microbiome literature · 4 October 2026
No eligible human intervention studies were included from today's PubMed records.
Open update ↗Daily microbiome literature · 3 October 2026
No eligible human intervention studies were included from today's PubMed records.
Open update ↗Daily microbiome literature · 2 October 2026
Two randomized placebo-controlled trials evaluated a heat-killed postbiotic in adults with excess weight and gastrointestinal discomfort, and Pediococcus acidilactici PA53 in adults with functional constipation.
Open update ↗Daily microbiome literature · 1 October 2026
A systematic review and meta-analysis evaluated live microorganism-based interventions for cognitive and muscle outcomes in aging adults.
Open update ↗Daily microbiome literature · 30 September 2026
A systematic review and meta-analysis evaluated Limosilactobacillus reuteri DSM 17938 for pediatric functional abdominal pain and functional constipation.
Open update ↗Daily microbiome literature · 29 September 2026
Two systematic reviews are included: microbiome-modifying supplementation and cognition in older adults, and probiotics for neonatal physiological jaundice.
Open update ↗Daily microbiome literature · 28 September 2026
Three human studies are included: a pectin trial in older adults with frailty, a probiotic network meta-analysis in colorectal cancer and an observational study after stroke; one additional eligible human study was read but not shown.
Open update ↗Daily microbiome literature · 27 September 2026
One exploratory human study reported pre-post changes during probiotic supplementation in patients with atopic dermatitis.
Open update ↗Daily microbiome literature · 26 September 2026
Three human studies are included: a dietary-fiber trial, a Lactobacillus meta-analysis and a pilot postbiotic trial; one additional eligible human study was read but not shown.
Open update ↗